Pricing Log in Create free account

MacroGenics, Inc. (MGNX) vs Sionna Therapeutics, Inc. (SION)

MacroGenics, Inc. and Sionna Therapeutics, Inc. are both Biotechnology companies. MacroGenics, Inc. and Sionna Therapeutics, Inc. are of similar size ($148.4M and $148.3M). Sionna Therapeutics, Inc. has the higher net margin (0.00% vs −8.70%) and the lower return on invested capital (−125.0% vs 0.00%). Across the 13 metrics below, Sionna Therapeutics, Inc. leads on 9 and MacroGenics, Inc. on 4.

Valuation

Metric MGNX SION Biotechnology median
P/E n/m n/m 10.60
P/S 0.88 n/m 9.40
P/B 3.46 0.56 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.61 0.57 0.66
EV/Sales (0.11) n/m 9.02
Earnings yield (9.44%) (66.46%) (32.88%)
Free cash flow yield (44.23%) (51.52%) (23.13%)

Profitability

Metric MGNX SION Biotechnology median
Gross margin 85.23% — 68.51%
Operating margin (20.45%) 0.00% 0.00%
Net margin (8.70%) 0.00% 0.00%
Free cash flow margin (39.08%) 0.00% 0.00%
Return on equity (32.61%) (32.34%) (51.96%)
Return on assets (4.94%) (30.66%) (46.06%)
Return on invested capital 0.00% (125.00%) 0.00%

Growth

Metric MGNX SION Biotechnology median
Revenue growth (TTM) 1.32% — 6.76%
EPS growth (last fiscal year) (10.28%) 88.24% 29.88%
Revenue growth, 5-year CAGR 7.35% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MGNX SION Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.96 20.05 4.97
Net debt to EBITDA 2.82 2.58 1.01

Dividend

Metric MGNX SION Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MGNX SION Biotechnology median
Market cap 148.42m 148.30m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack